Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
Daniel Simões(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Masoud Dara(World Health Organization Regional Office for Europe), Florian P. Maurer(Universität Hamburg), Ana Avellón(Instituto de Salud Carlos III), Askar Yedilbayev(World Health Organization Regional Office for Europe), Lara Vojnov(World Health Organization), Natalia Shubladze(National Center for Tuberculosis and Lung Disease), Anne S. Johansen(Institute of public health of Republic of Macedonia), Maja Stanojević(Dana-Farber Cancer Institute), Soudeh Ehsani(World Health Organization Regional Office for Europe), Francis Drobniewski(Imperial College London), Daniela María Cirillo(Vita-Salute San Raffaele University), Roger Paredes(Hospital Universitari Germans Trias i Pujol), Irina Felker(Novosibirsk Tuberculosis Research Institute), Nicole Seguy(World Health Organization Regional Office for Europe), Gulmira Kalmambetova
Cited by 9
Related Papers
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Evolution and transmission of drug-resistant tuberculosis in a Russian population
|Nature Genetics|2014|498
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|482
Gut Microbiota Linked to Sexual Preference and HIV Infection
|EBioMedicine|2016|480